Jurgen P. Debus

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 824 publications

Corrigendum to "Human mesenchymal stromal cells maintain their stem cell traits after high-LET particle irradiation - Potential implications for particle radiotherapy and manned space missions" [Cancer Lett. (2022), 524, 172-181].

Corrigendum to "Human mesenchymal stromal cells maintain their stem cell traits after high-LET particle irradiation - Potential implications for particle radiotherapy and manned space missions" [Cancer Lett. (2022), 524, 172-181].

Journal: Cancer letters

Published: August 25, 2026

Biologically optimized 3D range modulators for fast conformal carbon ion therapy:in vitrovalidation, treatment planning, and robustness analysis.

Biologically optimized 3D range modulators for fast conformal carbon ion therapy:in vitrovalidation, treatment planning, and robustness analysis.

Journal: Physics in medicine and biology

Published: August 20, 2026

The Prospective SPOTLESS Trial: Setup Accuracy of Tattoo-Less Surface-Guided Breast Radiotherapy Including Regional Nodal Irradiation.

The Prospective SPOTLESS Trial: Setup Accuracy of Tattoo-Less Surface-Guided Breast Radiotherapy Including Regional Nodal Irradiation.

Journal: Journal of clinical medicine

Published: July 02, 2026

Spatially Fractionated Induction Radiotherapy to Widen the Therapeutic Window in Locally Advanced Non-Small-Cell Lung Cancer (SPARROW): Study Protocol of a Multicenter, Randomized, Open-Label Seamless Phase I/II Trial.

Spatially Fractionated Induction Radiotherapy to Widen the Therapeutic Window in Locally Advanced Non-Small-Cell Lung Cancer (SPARROW): Study Protocol of a Multicenter, Randomized, Open-Label Seamless Phase I/II Trial.

Journal: Clinical lung cancer

Published: June 24, 2026

Hierarchical classification of immune cell transcriptomes at population-scale.

Hierarchical classification of immune cell transcriptomes at population-scale.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Hierarchical classification of immune cell transcriptomes at population-scale.

Hierarchical classification of immune cell transcriptomes at population-scale.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

The Role of Molecular Imaging in Ion Beam Therapy.

The Role of Molecular Imaging in Ion Beam Therapy.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Published: May 21, 2026

Future Challenges of Molecular Imaging in Oncology.

Future Challenges of Molecular Imaging in Oncology.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Published: May 21, 2026

Long-term outcomes of adjuvant proton radiotherapy (PRT) for residual pituitary adenoma (PA) in adults - a retrospective, single institute experience.

Long-term outcomes of adjuvant proton radiotherapy (PRT) for residual pituitary adenoma (PA) in adults - a retrospective, single institute experience.

Journal: Journal of neuro-oncology

Published: May 06, 2026

Influence of Interfractional Variations of Bladder and Rectal Filling on Vaginal Cuff Movement and the Role of Rectal Balloons in Gynecological Pelvic Proton Beam Therapy.

Influence of Interfractional Variations of Bladder and Rectal Filling on Vaginal Cuff Movement and the Role of Rectal Balloons in Gynecological Pelvic Proton Beam Therapy.

Journal: Technology in cancer research & treatment

Published: April 21, 2026

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

Journal: European urology

Published: April 15, 2026

Early ADC changes in risk-model-defined brain regions precede contrast-enhancing lesions after proton therapy for low-grade glioma.

Early ADC changes in risk-model-defined brain regions precede contrast-enhancing lesions after proton therapy for low-grade glioma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 14, 2026

Showing 1-12 of 824

Last Updated: 09/26/2026